Small Molecule Targeted Cancer Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Cancer Therapy Overall Market Size
2.1 Global Small Molecule Targeted Cancer Therapy Market Size: 2023 VS 2030
2.2 Global Small Molecule Targeted Cancer Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Cancer Therapy Players in Global Market
3.2 Top Global Small Molecule Targeted Cancer Therapy Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Cancer Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Small Molecule Targeted Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Small Molecule Targeted Cancer Therapy Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Small Molecules
4.1.4 Small Molecule Drug Conjugates
4.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2024
4.2.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2025-2030
4.2.3 By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Cancer Therapy Market Size, 2023 & 2030
5.1.2 Lymphoma
5.1.3 Melanoma
5.1.4 Multiple Myeloma
5.1.5 Breast Cancer
5.1.6 Prostate Cancer
5.1.7 Others
5.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2024
5.2.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2025-2030
5.2.3 By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Cancer Therapy Market Size, 2023 & 2030
6.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2024
6.2.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2025-2030
6.2.3 By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Cancer Therapy Revenue, 2019-2030
6.3.2 US Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.3.3 Canada Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.3.4 Mexico Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, 2019-2030
6.4.2 Germany Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4.3 France Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4.4 U.K. Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4.5 Italy Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4.6 Russia Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.4.8 Benelux Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, 2019-2030
6.5.2 China Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.5.3 Japan Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.5.4 South Korea Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.5.6 India Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Cancer Therapy Revenue, 2019-2030
6.6.2 Brazil Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.6.3 Argentina Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, 2019-2030
6.7.2 Turkey Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.7.3 Israel Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
6.7.5 UAE Small Molecule Targeted Cancer Therapy Market Size, 2019-2030
7 Small Molecule Targeted Cancer Therapy Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Small Molecule Targeted Cancer Therapy Major Product Offerings
7.1.4 Roche Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Major Product Offerings
7.2.4 Gilead Sciences Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Major Product Offerings
7.3.4 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Major Product Offerings
7.4.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Major Product Offerings
7.5.4 Bayer AG Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.5.5 Bayer AG Key News & Latest Developments
7.6 GSK
7.6.1 GSK Company Summary
7.6.2 GSK Business Overview
7.6.3 GSK Small Molecule Targeted Cancer Therapy Major Product Offerings
7.6.4 GSK Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.6.5 GSK Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Major Product Offerings
7.7.4 AstraZeneca Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Major Product Offerings
7.8.4 Johnson & Johnson Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Teva
7.9.1 Teva Company Summary
7.9.2 Teva Business Overview
7.9.3 Teva Small Molecule Targeted Cancer Therapy Major Product Offerings
7.9.4 Teva Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.9.5 Teva Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Small Molecule Targeted Cancer Therapy Major Product Offerings
7.10.4 Pfizer Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.10.5 Pfizer Key News & Latest Developments
7.11 Allergan
7.11.1 Allergan Company Summary
7.11.2 Allergan Business Overview
7.11.3 Allergan Small Molecule Targeted Cancer Therapy Major Product Offerings
7.11.4 Allergan Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.11.5 Allergan Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Small Molecule Targeted Cancer Therapy Major Product Offerings
7.12.4 Merck Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.12.5 Merck Key News & Latest Developments
7.13 Novartis
7.13.1 Novartis Company Summary
7.13.2 Novartis Business Overview
7.13.3 Novartis Small Molecule Targeted Cancer Therapy Major Product Offerings
7.13.4 Novartis Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.13.5 Novartis Key News & Latest Developments
7.14 Sanofi
7.14.1 Sanofi Company Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Small Molecule Targeted Cancer Therapy Major Product Offerings
7.14.4 Sanofi Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.14.5 Sanofi Key News & Latest Developments
7.15 Amgen
7.15.1 Amgen Company Summary
7.15.2 Amgen Business Overview
7.15.3 Amgen Small Molecule Targeted Cancer Therapy Major Product Offerings
7.15.4 Amgen Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.15.5 Amgen Key News & Latest Developments
7.16 AbbVie
7.16.1 AbbVie Company Summary
7.16.2 AbbVie Business Overview
7.16.3 AbbVie Small Molecule Targeted Cancer Therapy Major Product Offerings
7.16.4 AbbVie Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.16.5 AbbVie Key News & Latest Developments
7.17 Eli Lilly
7.17.1 Eli Lilly Company Summary
7.17.2 Eli Lilly Business Overview
7.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Major Product Offerings
7.17.4 Eli Lilly Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.17.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Small Molecule Targeted Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Small Molecule Targeted Cancer Therapy Market Drivers in Global Market
Table 3. Small Molecule Targeted Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Small Molecule Targeted Cancer Therapy in Global Market
Table 5. Top Small Molecule Targeted Cancer Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Small Molecule Targeted Cancer Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Small Molecule Targeted Cancer Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Small Molecule Targeted Cancer Therapy Product Type
Table 9. List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Roche Company Summary
Table 31. Roche Small Molecule Targeted Cancer Therapy Product Offerings
Table 32. Roche Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Roche Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Small Molecule Targeted Cancer Therapy Product Offerings
Table 36. Gilead Sciences Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Product Offerings
Table 40. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Offerings
Table 44. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Small Molecule Targeted Cancer Therapy Product Offerings
Table 48. Bayer AG Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Bayer AG Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Small Molecule Targeted Cancer Therapy Product Offerings
Table 52. GSK Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. GSK Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Small Molecule Targeted Cancer Therapy Product Offerings
Table 56. AstraZeneca Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Small Molecule Targeted Cancer Therapy Product Offerings
Table 60. Johnson & Johnson Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Small Molecule Targeted Cancer Therapy Product Offerings
Table 64. Teva Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Teva Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Small Molecule Targeted Cancer Therapy Product Offerings
Table 68. Pfizer Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. Pfizer Key News & Latest Developments
Table 70. Allergan Company Summary
Table 71. Allergan Small Molecule Targeted Cancer Therapy Product Offerings
Table 72. Allergan Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Allergan Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Small Molecule Targeted Cancer Therapy Product Offerings
Table 76. Merck Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. Merck Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Small Molecule Targeted Cancer Therapy Product Offerings
Table 80. Novartis Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Novartis Key News & Latest Developments
Table 82. Sanofi Company Summary
Table 83. Sanofi Small Molecule Targeted Cancer Therapy Product Offerings
Table 84. Sanofi Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. Sanofi Key News & Latest Developments
Table 86. Amgen Company Summary
Table 87. Amgen Small Molecule Targeted Cancer Therapy Product Offerings
Table 88. Amgen Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 89. Amgen Key News & Latest Developments
Table 90. AbbVie Company Summary
Table 91. AbbVie Small Molecule Targeted Cancer Therapy Product Offerings
Table 92. AbbVie Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 93. AbbVie Key News & Latest Developments
Table 94. Eli Lilly Company Summary
Table 95. Eli Lilly Small Molecule Targeted Cancer Therapy Product Offerings
Table 96. Eli Lilly Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 97. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Small Molecule Targeted Cancer Therapy Segment by Type in 2023
Figure 2. Small Molecule Targeted Cancer Therapy Segment by Application in 2023
Figure 3. Global Small Molecule Targeted Cancer Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2023
Figure 8. By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 16. US Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 28. China Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Roche Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Gilead Sciences Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bayer AG Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. GSK Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. AstraZeneca Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Johnson & Johnson Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Teva Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Pfizer Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Allergan Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Merck Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Novartis Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Sanofi Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Amgen Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. AbbVie Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Eli Lilly Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
